M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice

References

Page 1

	Year	Citations
Clozapine for the Treatment-Resistant Schizophrenic John M. Kane Archives of General Psychiatry	1988	4.1K
The Essential Role of Hippocampal CA1 NMDA Receptor–Dependent Synaptic Plasticity in Spatial Memory Joe Z. Tsien, Patricio T. Huerta, Susumu Tonegawa Cell Synaptic PlasticityCognitive ScienceEssential RoleSynaptic SignalingMedicine	1996	1.8K
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. Herbert Y. Meltzer, Shin Matsubara, J C Lee Journal of Pharmacology and Experimental Therapeutics	1989	1.4K
Recombinant BDNF Rescues Deficits in Basal Synaptic Transmission and Hippocampal LTP in BDNF Knockout Mice Susan L. Patterson, Ted Abel, Thomas A. Deuel, Neuron	1996	1.2K
Voltage-clamp analysis of muscarinic excitation in hippocampal neurons J. V. Halliwell, Paul R. Adams Brain Research NeurophysiologySocial SciencesNeurologyNeurotransmissionNeuroscience	1982	1K
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers Anil K. Malhotra Neuropsychopharmacology Nmda Receptor FunctionNeurophysiologyMedicineHealthy VolunteersBehavioral Pharmacology	1996	694
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. John H. Kehne, B M Baron, A A Carr, Journal of Pharmacology and Experimental Therapeutics	1996	358
Postsynaptic factors control the duration of synaptic enhancement in area CA1 of the hippocampus Robert C. Malenka Neuron Synaptic PlasticityCellular NeurobiologyNeurodynamicsNeuromodulationNeurophysiology	1991	325
Synaptic activation of N‐methyl‐D‐aspartate receptors in the Schaffer collateral‐commissural pathway of rat hippocampus. Graham L. Collingridge, Caroline E. Herron, R.A.J. Lester The Journal of Physiology	1988	276
Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. S.M. Sorensen, John H. Kehne, Gina M. Fadayel, Journal of Pharmacology and Experimental Therapeutics	1993	256

Page 1